A Safety Study of IVMED-85 Ophthalmic Solution in Healthy Adults

Part of paid clinical trials in Memphis, Tennessee.

Sponsor
iVeena Delivery Systems, Inc.
Study ID
NCT07370584
Phase
PHASE1
Status
Recruiting
Apply to this trial

Conditions

  • Safety Study

Eligibility Criteria

Sex
ALL
Age
18 Years - 49 Years
Healthy Volunteers
Accepted

Interventions

  • IVMED-85 ophthalmic solution — DRUG
    IVMED-85 ophthalmic solution (0.20 mg/mL), administer twice a day (morning and evening) in both eyes
  • Vehicle Ophthalmic Solution — DRUG
    Vehicle ophthalmic solution, administer twice a day (morning and evening) in both eyes

Study Details

The purpose of this trial is to determine the safety of IVMED-85 eye drops in healthy adult subjects. Participants will be assigned to either the active or vehicle eyedrop group. The participants will receive eye drops twice daily for 6 weeks. Participants will not know which eyedrop they are taking.

Key Dates

Start date
Feb 4, 2026
Status verified
Feb 2026
Primary completion
May 31, 2026
Completion
Jul 31, 2026

Study Design

Enrollment
36 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Placebo Comparator: Vehicle ophthalmic solution
    Vehicle ophthalmic solution, administered twice a day
  • Experimental: IVMED-85 ophthalmic solution
    IVMED-85 ophthalmic solution (0.20 mg/mL)

Primary Outcome Measure

Visual acuity [ Time Frame: From enrollment to the end of treatment at 6 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Total Eye Care, P.A.MemphisTennessee38119-

Find similar trials in Memphis, TN

By research site
Total Eye Care, P.A.· Memphis, TN

Related Studies